We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Peer review

7 December 2020 By Liam Proud

After three failed IPOs, the private-equity firm may sell publisher Springer Nature to a new fund it controls for 6 bln euros, the FT says. It’s messy, but probably better than a botched listing. With public investors wary of sluggish assets, other deals may face a similar fate.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)